News | May 20, 2007

New Welch Allyn Spot-Check and Patient Monitoring Devices Feature Masimo SET Pulse Oximetry Option

May 21, 2007 — Welch Allyn and Masimo Corp. have partnered to incorporate Masimo SET pulse oximetry into new versions of the Welch Allyn Spot Vital Signs and Welch Allyn Propaq LT devices.

The two devices allow clinicians to effectively spot check and monitor patients respectively in ambulatory and acute care settings, and can be easily configured for efficient, safe and accurate operation by caregivers with varying levels of training and sophistication.

Masimo SET is clinically proven in more than 100 independent and objective studies to provide the most trustworthy arterial blood oxygen saturation and pulse rate measurements even under the most difficult clinical conditions, including patient motion and low peripheral perfusion. These studies prove Masimo SET delivers improvements in outcomes, safety and efficiency while decreasing costs.

"We are very pleased to extend our current business relationship with Masimo as we strive to offer our customers the safest and most accurate monitoring technologies available," said Doug Linquest, executive vice president, Monitoring and Defibrillation at Welch Allyn. "By continuing to integrate Masimo SET pulse oximetry technology into our extensive line of spot-check and monitoring systems, we are able to give caregivers the capability to monitor SpO2 in more patients in places they never thought possible."

Spot Vital Signs is a fully automated, multiparameter spot-check device that captures noninvasive blood pressure measurements using the oscillometric method. In addition to a pulse oximetry option, it also offers Welch Allyn's SureTemp fast predictive thermometry which gives providers the option of performing oral, axillary or rectal temperature readings. Spot Vital Signs can also transfer data from the device into patients' electronic medical records (EMR) via infrared connectivity, and is designed to interface with the Welch Allyn Connex Data Management System in acute care settings.

The Propaq LT patient monitor can be used in a number of bedside, transport and ambulatory applications. It is deployable in areas in and outside the hospital, and comes equipped to monitor heart rate, 3- or 5-lead ECG, noninvasive blood pressure, SpO2, and respiration with an easy-to-use interface. It features a full-color LCD screen and can be configured for use on neonatal, pediatric and adult patients. The Propaq LT can be operated in standalone mode or wirelessly networked to Welch Allyn's Acuity Central Monitoring Station, and it can easily download data to a PC and customer EMRs.

"One of Welch Allyn's top priorities is to bring patient monitoring to the presently unmonitored bed, which makes up over 80 percent of today's hospital beds," added Linquest. "These beds are typically general care or medical-surgical beds and require advanced and connected spot-check vital signs devices. The new Propaq LT monitor effectively bridges the gap (cost, size and complexity) between today's continuous patient monitors and spot-check devices like Spot Vital Signs that offer even more comprehensive clinical benefits to the unmonitored bed."

"This partnership confirms the strength of our business relationship with Welch Allyn and the commitment of both companies to bring best-in-class patient monitoring technology to new clinical sites," said Joe E. Kiani, chairman and CEO of Masimo Corp. "We are happy that by partnering with Welch Allyn, we can offer the proven benefits of Masimo SET pulse oximetry to more clinicians and patients in more diverse clinical settings."

For more information call 800.535.6663 or visit www.welchallyn.com.

Related Content

ScImage Awarded U.S. Government DIN-PACS IV Contract
News | PACS | August 16, 2017
ScImage Inc. was recently awarded a new DIN-PACS IV (Digital Imaging Network/Picture Archiving and Communications...
Neighbors Emergency Center Selects Novarad PACS/RIS
News | PACS | August 15, 2017
August 15, 2017 — Novarad Corp.
Fujifilm Launches Synapse PACS Version 5
Technology | PACS | August 03, 2017
August 3, 2017 – Fujifilm Medical Systems U.S.A. Inc.
RamSoft has teamed up with Availity to bring healthcare providers Patient Access and Patient Authorizations
News | PACS | July 31, 2017
RamSoft has teamed up with Availity to bring healthcare providers Patient Access and Patient Authorizations, two fully...
Agfa Receives FDA 510(k) for Xtend Functionalities on Xero Universal Viewer
Technology | Remote Viewing Systems | July 27, 2017
Agfa HealthCare announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Xero Xtend...
Philips Receives FDA 510(k) Clearance for IntelliSpace Portal 9.0
Technology | Advanced Visualization | June 29, 2017
Philips announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market...
Envision Diagnostic Center Deploys Exa PACS Across 11 Facilities
News | Enterprise Imaging | June 28, 2017
Envision Diagnostic Center (Novi, Mich.) has implemented Exa PACS (picture archiving and communication system) from...
Fujifilm's Synapse PACS Granted Authority to Operate Under New U.S. DoD Process
News | PACS | June 26, 2017
June 26, 2017 — Fujifilm Medical Systems U.S.A. Inc.
News | PACS | June 23, 2017
Medidata and Median Technologies announced a new collaboration to streamline the growth and use of medical imaging in...
RamSoft Partners With Gamel to Enhance Patient Care in Peruvian Market
News | PACS | June 23, 2017
RamSoft announced a new partnership with Peru-based medical imaging equipment provider, Gamel. With RamSoft’s...
Overlay Init